Main Article Content
We have observed 55 patients with diabetes mellitus (DM) type 2 and obesity without signs of thyroid function abnormality, as well as 60 patients with DM type 2 and obesity combined with overt or subclinical hypothyroidism. The objective of the study was to evaluate the indicators of thyroid functional state in patients with type 2 DM and obesity. It is shown that patients with type 2 DM combined with hypothyroidism have a higher incidence of hypertriglyceridemia. In these patients, there are higher rates of body weight, low-density lipoproteins (LDL) than in patients with type 2 DM without thyroid dysfunction. Patients with type 2 DM in combination with symptomatic hypothyroidism are characterized by higher levels of body weight, total cholesterol, LDL, triglycerides and lower high-density lipoproteins indicators than those with DM type 2 associated with subclinical thyroid dysfunction. With an increasing number of metabolic syndrome components, deterioration in carbohydrate and lipid metabolism is being detected in examined patients that can lead to increased cardiovascular risks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Grundmann N., Mielck A., Siegel M., Maier W. Area deprivation and the prevalence of type 2 diabetes and obesity: analysis at the municipality level in Germany // BMC Public Health. — 2014. — 14. — 1264. — doi: 10.1186/1471-2458-14-1264.
Vanderpump M. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey / M. Vanderpump, W. Tunbridge, J. French // Clinical Endocrino-logy. — 1995. — Vol. 43. — P. 55-58.
Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado Thyroid Disease Prevalence Study // Archives of Internal Medicine. — 2000. — Vol. 160, № 4. — P. 526-534.
Hollowell J.G., Staehling N.W., Flanders W.D. et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey // J. Clin. Endocrinol. Metab. — 2002. — Vol. 87. — P. 489-499.
Maratou E., Hadjidakis D.J., Kollias A. et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism // European Journal of Endocrinology. — 2009. — Vol. 160, № 5. — P. 785-790.
Chen H.S., Wu T.E.J., Jap T.S. et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients // Diabetic Medicine. — 2007. — Vol. 24, № 12. — P. 1336-1344.
Щитовидная железа и менопаузальный метаболический синдром / Дерябина Е.Г., Башмакова Н.В. // Вестник Уральской медицинской академической науки. — 2009. — № 4. — С. 18-20.
Maratou E., Hadjidakis D.J., Peppa M. et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism // Eur. J. Endocrinol. — 2010. — Vol. 163. — P. 625-630.
Rezzonico J., Rezzonico M., Pusiol E. et al. Introducing the thyroid gland as another victim of the insulin resistance syndrome // Thyroid. — 2008. — Vol. 18. — P. 461-464.